| Literature DB >> 33139651 |
Claudia Stracquadanio1,2, Juan Manuel Quiles3, Giuseppe Meca3, Santa Olga Cacciola2.
Abstract
Trichoderma spp. are known as biocontrol agents of fungal plant pathogens and have been recognized as a potential source of bioactive metabolites. The production of antimicrobial substances from strains T. atroviride (TS) and T. asperellum (IMI 393899) was investigated. The bioactivity of 10- and 30-day culture filtrate extracted with ethyl acetate was assessed against a set of pathogenic fungi and oomycetes. The 30-day extracts of both strains had significant cytotoxic effects against the tested pathogens, with values of minimum fungicidal concentration (MFC) ranging between 0.19 and 6.25 mg/mL. Dual culture assay (direct contact and nondirect contact) and the percentage inhibition of radial growth (PIRG) was calculated. The highest PIRG values were 76% and 81% (direct contact) with IMI 393899 and TS, respectively. Nondirect contact does not show inhibition on any of pathogens tested, indicating that the inhibition is not due to the secretion of volatile substances. Culture filtrates were analyzed by GC-MS and HPLC-Q-TOF-MS for the identification of volatile organic compounds (VOCs) and nonvolatile organic compounds (nVOCs), respectively. Seven classes of VOCs and 12 molecules of nVOCs were identified. These results indicate that these strains of Trichoderma had antimicrobial activities and they are potential natural sources of compounds with biological activity.Entities:
Keywords: Trichoderma asperellum; Trichoderma atroviride; bioactive metabolites; biological control; plant pathogens
Year: 2020 PMID: 33139651 PMCID: PMC7712451 DOI: 10.3390/jof6040263
Source DB: PubMed Journal: J Fungi (Basel) ISSN: 2309-608X
Agar diffusion test of 30-days EtOAc extracts. Several concentrations of the EtOAc extracts of Trichoderma asperellum IMI393899 and T. atroviride TS were tested on different pathogens; results were measured as the diameter of the inhibition halos. * Range below 5 mm (-), 5–10 mm (+), range 11–15 mm (++), range 16–20 mm (+++), range 21–25 mm (++++), and more than 26 mm (+++++).
| Strains | * EtOAc Extracts of | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
| |||||||||||
| Concentrations mg/mL | 0 | 1 | 10 | 25 | 50 | 100 | 0 | 1 | 10 | 25 | 50 | 100 |
|
| - | - | + | ++ | +++ | +++ | - | - | + | ++ | ++ | ++ |
|
| - | - | + | +++ | +++ | +++ | - | - | + | + | ++ | ++ |
|
| - | + | ++ | ++ | +++ | +++ | - | - | + | ++ | ++ | ++ |
|
| - | - | + | ++ | ++ | ++++ | - | - | + | + | + | ++ |
|
| - | ++ | ++ | +++ | ++++ | +++++ | - | - | + | + | ++ | ++ |
|
| - | - | + | ++ | +++ | ++++ | - | - | + | + | + | ++ |
|
| - | - | ++ | ++ | ++ | +++ | - | - | + | + | + | ++ |
|
| - | - | + | + | +++ | ++++ | - | - | - | - | + | ++ |
|
| - | - | ++ | ++ | ++ | ++++ | - | - | + | + | ++ | ++ |
|
| - | + | + | ++++ | ++++ | +++++ | - | - | + | + | ++ | ++ |
|
| - | ++ | +++ | +++++ | +++++ | +++++ | - | - | + | ++ | ++ | ++ |
|
| - | + | + | +++ | +++++ | ++++ | - | - | + | + | + | ++ |
|
| - | - | ++ | +++ | ++++ | +++++ | - | - | + | + | ++ | ++ |
|
| - | - | ++ | ++ | +++ | +++ | - | - | + | + | ++ | ++ |
|
| - | - | + | ++ | +++ | ++++ | - | - | - | + | ++ | ++ |
|
| - | - | ++ | ++ | +++ | ++++ | - | - | + | + | + | ++ |
|
| - | - | + | + | ++ | +++ | - | - | - | + | ++ | ++ |
|
| - | - | ++ | ++ | ++ | +++ | - | - | + | + | ++ | ++ |
|
| - | - | + | ++ | +++ | ++++ | - | - | - | + | ++ | ++ |
|
| - | - | + | +++ | +++++ | +++++ | - | - | + | +++ | ++++ | +++++ |
|
| - | - | + | +++ | +++++ | +++++ | - | - | + | +++ | ++++ | +++++ |
|
| - | - | + | ++ | +++ | +++ | - | - | + | + | ++ | +++ |
|
| - | - | + | + | +++ | +++++ | - | - | - | + | ++ | +++ |
|
| - | - | ++ | +++ | ++++ | +++++ | - | - | + | ++ | ++ | ++++ |
|
| - | - | ++ | +++ | ++++ | +++++ | - | - | ++ | ++++ | +++ | +++++ |
Figure 1Agar diffusion test of Trichoderma asperellum IMI393899 extract. The picture shows the halos of antifungal activity at different concentrations (1, 10, 25, 50, and 100 mg/mL) of 30-days EtOAc extract and in comparison with the "C" control (10% DMSO) on Penicillium camemberti (A), Aspergillus carbonarius (B), Fusarium verticillioides (C), Neofusicoccum parvum (D), Colletotrichum acutatum (E), and Phytophthora nicotianae (F).
Figure 2Agar diffusion test of Trichoderma atroviride TS extract. The picture shows the halos of antifungal activity at different concentrations (1, 10, 25, 50, and 100 mg/mL) of 30-days EtOAc extract and in comparison with the "C" control (10% DMSO) on Fusarium proliferatum (A), Penicillium brevicopactum (B), Aspergillus Flavus (C), Neofusicoccum batangarum (D), Colletotrichum gloeosporioides (E), and Phytophthora parvispora (F).
Minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC). Values of the EtOAc extracts of Trichoderma asperellum IMI393899 and T. atroviride TS on tested fungus and oomycete pathogens.
| Strains | EtOAc Extract of | |||
|---|---|---|---|---|
|
|
| |||
| MIC | MFC | MIC | MFC | |
|
| 0.39 | 0.78 | 3.13 | 3.13 |
|
| 0.78 | 0.78 | 3.13 | 6.25 |
|
| 0.39 | 1.56 | 1.56 | 3.13 |
|
| 0.39 | 1.56 | 1.56 | 3.13 |
|
| 0.39 | 0.78 | 1.56 | 3.13 |
|
| 0.19 | 0.78 | 1.56 | 3.13 |
|
| 0.09 | 0.39 | 0.19 | 0.39 |
|
| 0.09 | 0.39 | 0.19 | 0.39 |
|
| 0.09 | 0.39 | 0.19 | 0.78 |
|
| 0.09 | 0.39 | 0.19 | 0.39 |
|
| 0.19 | 0.78 | 0.39 | 0.78 |
|
| 0.09 | 0.39 | 0.19 | 0.78 |
|
| 0.39 | 0.78 | 1.56 | 1.56 |
|
| 0.39 | 0.78 | 3.13 | 6.25 |
|
| 0.39 | 0.78 | 3,13 | 6.25 |
|
| 0.39 | 0.78 | 1.56 | 3.13 |
|
| 0.09 | 0.19 | 0.78 | 1.56 |
|
| 0.39 | 0.78 | 1.56 | 3.13 |
|
| 0.39 | 0.78 | 3.13 | 3.13 |
|
| 0.39 | 0.78 | 0.78 | 0.78 |
|
| 0.78 | 0.78 | 0.78 | 1.56 |
|
| 0.19 | 0.78 | 0.19 | 0.78 |
|
| 0.39 | 1.56 | 0.78 | 1.56 |
|
| 0.39 | 0.78 | 0.78 | 0.78 |
|
| 0.39 | 0.78 | 0.78 | 1.56 |
The percentage inhibition of radial growth (PIRG) in dual culture assay. Results are expressed as the ± standard error of PIRG after 1-, 3-, and 7-day incubation; * Represents pathogens that showed signs of mycelial lysis due to mycoparasitism by Trichoderma asperellum IMI393899 and T. atroviride TS; a Not Determined
| Strains |
|
| ||||
|---|---|---|---|---|---|---|
| First Day | Third Day | Seventh Day | First Day | Third Day | Seventh Day | |
|
| 3.64 ± 1.82 | 37.78 ± 2.00 | 63.75 ± 2.6 * | 14.55 ± 3.64 | 36.67 ± 1.67 | 67.50 ± 1.44 * |
|
| 6.45 ± 3.23 | 43.75 ± 0.83 | 54.17 ± 0.42 * | 8.06 ± 2.79 | 41.35 ± 0.48 | 63.33 ± 2.32 * |
|
| ND a | 3.17 ± 1.59 | 46.28 ± 2.19 | ND | ND | 47.93 ± 1.43 |
|
| ND | 10.26 ± 1.28 | 59.01 ± 0 * | 13.33 ± 3.33 | 14.10 ± 1.28 | 58.39 ± 2.24 |
|
| ND | 9.09 ± 0 | 48.62 ± 0.92 * | ND | 9.09 ± 0 | 44.95 ± 0 |
|
| 5.77 ± 1.92 | 22.39 ± 1.49 | 76.24 ± 2.97 * | 7.69 ± 0 | 25.37 ± 1.49 | 81.19 ± 0.99 * |
|
| ND | 3.03 ± 1.52 | 56.52 ± 1.26 * | ND | ND | 71.01 ± 2.61 * |
|
| ND | 20.00 ± 4.00 | 51.85 ± 1.85 | ND | 12.00 ± 4.00 | 68.52 ± 1.85 * |
|
| ND | ND | 18.18 ± 3.15 | ND | ND | 30.91 ± 7.93 |
|
| ND | ND | 51.67 ± 0.83 * | ND | 7.02 ± 1.75 | 75.83 ± 6.01 * |
|
| ND | ND | 25.71 ± 12.45 | ND | 9.09 ± 4.55 | 28.57 ± 10.30 |
|
| ND | 11.11 ± 5.56 | 43.90 ± 2.44 | ND | 22.22 ± 14.70 | 68.29 ± 4.88 |
|
| ND | 15.79 ± 5.26 | 42.42 ± 6.06 * | ND | 21.05 ± 9.12 | 63.64 ± 5.25 * |
|
| 2.70 ± 0 | 4.82 ± 1.20 | 46.05 ± 0.66 | 13.51 ± 2.70 | 16.87 ± 7.23 | 50.00 ± 7.59 |
|
| ND | 4.11 ± 1.37 | 38.52 ± 0 | ND | 4.11 ± 2.74 | 22.95 ± 3.57 |
|
| ND | 8.99 ± 1.95 | 45.86 ± 1.69 | ND | ND | 41.40 ± 3.87 |
|
| ND | ND | 42.22 ± 1.11 | ND | ND | 25.56 ± 1.11 * |
|
| ND | 6.82 ± 1.14 | 40.58 ± 0.72 | ND | ND | 23.91 ± 2.17 |
|
| ND | 4.11 ± 2.74 | 34.55 ± 1.57 | 8.11 ± 2.70 | 9.59 ± 4.11 | 21.82 ± 0.91 |
|
| ND | 10.94 ± 2.71 | 50 ± 0.96 * | ND | 6.25 ± 0 | 42.31 ± 1.67 * |
|
| 7.69 ± 0 | 9.59 ± 0 | 45.83 ± 3.00 | 7.69 ± 0 | 8.22 ± 1.37 | 35.83 ± 1.67 * |
|
| ND | 5.88 ± 3.11 | 50 ± 2.47 * | ND | 3.53 ± 1.18 | 39.73 ± 1.37 * |
|
| ND | 1.67 ± 1.67 | 42.57 ± 0.99 * | ND | 3.33 ± 1.67 | 30.69 ± 5.51 |
|
| ND | 12.82 ± 5.13 | 67.15 ± 2.53 * | ND | 2.56 ± 1.28 | 48.91 ± 1.93 * |
|
| ND | 3.03 ± 3.03 | 61.19 ± 5.22 * | ND | 6.06 ± 1.52 | 51.49 ± 1.97 |
Figure 3Dual culture assay after 7-days of incubation. Fusarium graminearum (A), Penicillium commune (B), and Aspergillus parasiticus (C) in coculture (left side of each plate) with Trichoderma atroviride TS (a), Trichoderma asperellum IMI393899, (b) and the control (c).
Volatile organic compounds (VOCs) produced in the culture filtrate of Trichoderma asperellum IMI393899 and T. atroviride TS identified by GC-MS. Results are expressed as mean relative abundance percentages (as obtained by dividing the area of each peak by the total area of the chromatogram peaks) ± standard deviation.
| Compound (VOCs) | Strains | |
|---|---|---|
|
|
| |
|
| ||
| Ethanol | 0.58 ± 0.01 | 1.02 ± 0.07 |
| 2-methyl-1-propanol | 0.70 ± 0.01 | 0.68 ± 0.05 |
| 3-methyl-1-butanol | 4.47 ± 0.13 | 5.29 ± 0.23 |
| 3-methyl acetate-1-butanol | 0.35 ± 0.01 | ND |
| 2-methyl acetate-1-butanol | 0.18 ± 0.01 | ND |
| Benzyl alcohol | 0.35 ± 0.05 | ND |
| Phenylethyl Alcohol | 19.06 ± 0.08 | ND |
| 1-phenyl-2-propanol | ND * | 0.15 ± 0 |
| 2-(4-methoxyphenyl)ethanol | 0.71 ± 0.03 | ND |
|
| ||
| Benzaldehyde | 0.13 ± 0 | 0.20 ± 0 |
| Benzeneacetaldehyde | 0.06 ± 0 | 0.91 ± 0.04 |
| 3-methyl-benzaldehyde | 0.30 ± 0.01 | ND |
| Nonanal | ND | 0.11 ± 0 |
|
| ||
| 1-methyl-6-oxopyridine-3-carboxylic acid | ND | 0.20 ± 0.01 |
|
| ||
| 2,3-butandione | ND | 1.25 ± 0.04 |
| 3-ethyl-2-cyclopenten-1-one | 0.41 ± 0.03 | 0.87 ± 0.08 |
| Phenylacetone | ND | 0.23 ± 0.02 |
| 5,6,6-trimethyl-3,4-undecadiene-2,10-dione | 0.27 ± 0.02 | 1.55 ± 0.02 |
|
| ||
| Trimethyl pyrazine | 0.09 ± 0.01 | 0.43 ± 0.03 |
| Tetramethyl pyrazine | 4.81 ± 0.04 | 56.79 ± 0.29 |
| 2,3,5-trimethyl-6-ethylpyrazine | 0.45 ± 0.01 | 1 ± 0.06 |
| 2,3,5-trimethyl-6-propylpyrazine | 0.14 ± 0 | 0.14 ± 0.01 |
| 2-methyl-3,5-diethylpyrazine | ND | 0.74 ± 0.02 |
| Trimethylisobutylpyrazine | ND | 0.86 ± 0.07 |
| 2,3-dimethyl-5-(1-propenyl)pyrazine | 0.04 ± 0 | ND |
|
| ||
| Ethyl acetate | 0.62 ± 0.01 | 0.46 ± 0 |
| Ethyl isobutyrate | 0.15 ± 0.02 | ND |
| Isobutyl butanoate | 0.22 ± 0.01 | ND |
| Ethyl β-hydroxybutyrate | 0.11 ± 0.01 | 0.22 ± 0 |
| Isoamyl 2-methylpropanoate | 0.18 ± 0.01 | ND |
| Butyl isobutyrate | 0.10 ± 0 | ND |
| Ethyl 3-acetoxybutanoate | ND | 0.34 ± 0.01 |
| β-phenylethyl formate | 0.14 ± 0.01 | ND |
| Ethyl benzeneacetate | ND | 1.16 ± 0.09 |
| 2-phenethyl acetate | 1.15 ± 0.05 | ND |
| Pentanoic acid, oct-4-yl ester | ND | 0.66 ± 0.07 |
| Isobutyl phenylacetate | ND | 0.08 ± 0.01 |
| α-phenylethyl butyrate | 0.41 ± 0.01 | ND |
| Butyl adipate | ND | 0.26 ± 0.02 |
|
| ||
| 2,2-diphenyl-2H-1-benzopyran | 0.22 ± 0.02 | ND |
| Trimethyloxazole | ND | 0.83 ± 0.03 |
| 2-pentyl furan | 0.19 ± 0.01 | ND |
| Methyl hydroxytriazaindolizine | 0.08 ± 0 | ND |
| 5,6,7,8-tetrahydro-2-methyl-4H-chromen-4-one | 0.23 ± 0.01 | 1.38 ± 0.08 |
| Methyl 3,4-di-O-acetyl-2-O-methylfucofuranoside | 0.16 ± 0.01 | ND |
| 1,3-di-tert-butylbenzene | 0.20 ± 0.02 | 0.48 ± 0.18 |
| 2,4-dimethyl-3-acetylpyrrole | ND | 0.29 ± 0.04 |
| 6,7-dimethyl-1,2,3,5,8,8a-hexahydronaphthalene | 0.22 ± 0.03 | ND |
| 3-methylhexyl isothiocyanate | ND | 1.39 ± 0.10 |
| 6-pentyl-alpha-pyrone | 42.66 ± 0.15 | 0.26 ± 0 |
| α-Himachalene | 2.14 ± 0.13 | 0.61 ± 0.01 |
| α-Zingiberene | 5.86 ± 0.01 | 2.67 ± 0.14 |
| 1-hydroxy-2,4-di-tert-butylbenzene | 2.50 ± 0.04 | 6.17 ± 0.04 |
| Butylated hydroxytoluene | 0.58 ± 0.01 | 1.66 ± 0.11 |
| α-Sesquiphellandrene | 6.60 ± 0.07 | 2.43 ± 0.05 |
| Nerolidol | ND | 0.86 ± 0.01 |
| Cedrene | 0.34 ± 0.08 | ND |
| 6,7-dihydro-2-trans-farnesol | 0.63 ± 0.04 | ND |
| 1,2,4,4,6-pentamethyl-1,4-dihydropyridine-3,5-dicarbonitrile | ND | 1.19 ± 0.01 |
| Ledol | 0.95 ± 0.02 | 3.04 ± 0.36 |
| Phenol, 2-(1,1-dimethylethyl)-4-(1-methyl-1-phenylethyl | 0.26 ± 0 | 1.15 ± 0.76 |
* Not Determined.
Nonvolatile compounds (nVOCs) in the EtOAc extracts after 10 and 30 days of incubation identified by HPLC-Q-TOF-MS.
| Compound (nVOCs) | MW | Molecular Formula | m/z | Ion | RT | Days of Fermentation | Reference |
|---|---|---|---|---|---|---|---|
| Trichodermaerin | 316.20 | C20 H28 O3 | 317.2104 | [M+H]+ | 15.9 | 30 | [ |
| Aspereline H | 978.62 | C47 H82 N10 O12 | 977.6099 | [M-H]− | 16.7 | 10 | [ |
| Aspereline A | 936.60 | C45 H80 N10 O11 | 935.5956 | [M-H]− | 19.3 | 10 | [ |
| Aspereline E | 952.60 | C45 H80 N10 O12 | 951.5935 | [M-H]− | 16.6 | 10 | [ |
| Methylcordysinin A | 240.15 | C12 H20 N2 O3 | 299.1628 | [M+CH3COO]− | 20.7 | 10 | [ |
| 3,5,9-trihydroxyergosta-7,22-dien- 6-one | 444.32 | C28 H44 O4 | 489.3224 | [M-HCOO]− | 9.4 | 30 | [ |
| Ergosta-7,22-dien-3-ol | 398.36 | C28 H46 O | 397.3486 | [M-H]− | 30.3 | 10–30 | [ |
| Beta-sitosterol | 414.39 | C29 H50 O | 413.3784 | [M-H]− | 33.3 | 10 | [ |
| Adenine nucleoside | 267.10 | C10 H13 N5 O4 | 312.0953 | [M-HCOO]− | 5.5 | 30 | [ |
| Atrichodermone B | 156.08 | C8 H12 O3 | 215.0914 | [M+CH3COO]− | 9.3 | 30 | [ |
| Atrichodermone C | 236.18 | C15 H24 O2 | 295.1906 | [M+CH3COO]− | 23.5 | 30 | [ |
| 6-pent-1-enyl-pyran-2-one | 164.08 | C10 H12 O2 | 165.0915 | [M+H]+ | 9.9 | 30 | [ |
Figure 4Chemical structure of the nonvolatile compounds (nVOCs) identified in the Trichoderma asperellum (IMI 393899) and Trichoderma atroviride (TS) EtOAc extracts. (a) aspereline A; (b) trichodermaerin; (c) methylcordysinin a; (d) aspereline E; (e) adenine nucleoside; (f) 6-pent-1-enyl-pyran-2-one; (g) aspereline H; (h) atrichodermone B; (i) atrichodermone C; (j) ergosta-7,22-dien-3-ol; (k) 3,5,9-trihydroxyergosta-7,22-dien-6-one; and (l) beta-sitosterol.